Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

4.9K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Harmonizing regional cancer registry data to facilitate Germany-wide epidemiological analyses.

International journal of medical informatics·2026
Same author

Population Skin Cancer Screening and Melanoma Mortality Rates.

JAMA dermatology·2026
Same author

Ascertainment of Cancer Cases in the German National Cohort (NAKO): Methods and Initial Results.

Deutsches Arzteblatt international·2026
Same author

Supplemental Breast Ultrasound in Mammography Screening for Women with Critically Dense Breasts.

Cancers·2026
Same author

Clinical characteristics and survival of small cell lung cancer with limited or extensive synchronous metastatic spread - A German population-based cancer-registry based cohort study.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Communication-related aspects drive senior patients' satisfaction with the process of decision-making in cancer therapy.

Scientific reports·2026

Related Experiment Video

Updated: Jun 30, 2025

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.6K

[Structured screening for sporadic breast cancer].

Stefanie Weigel1, Alexander Katalinic2

  • 1Klinik für Radiologie und Referenzzentrum Mammographie Münster, Universität Münster und Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Deutschland. weigels@uni-muenster.de.

Radiologie (Heidelberg, Germany)
|March 19, 2024
PubMed
Summary

Germany's mammography screening program (MSP) effectively reduces breast cancer mortality by detecting cancers early. Expanding the MSP to ages 45-75 will increase access to quality-assured screenings.

Keywords:
Advanced tumor stagesAge expansionBreast cancerDigital breast tomosynthesisMammography screening

More Related Videos

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.3K
Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

5.5K

Related Experiment Videos

Last Updated: Jun 30, 2025

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.6K
gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.3K
Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

5.5K

Area of Science:

  • Oncology
  • Public Health
  • Preventive Medicine

Background:

  • Secondary prevention of breast cancer aims to reduce mortality by early detection.
  • Germany established a nationwide mammography screening program (MSP) in 2005.
  • The MSP complements prevention projects for high-risk individuals.

Purpose of the Study:

  • To provide an overview of the current status of the German MSP.
  • To discuss the upcoming expansion of age groups covered by the MSP.
  • To explore potential future developments and optimizations for the MSP.

Main Methods:

  • A narrative review approach was employed.
  • Literature and data searches were guided by the study's topics.
  • The review synthesized existing information on the MSP.

Main Results:

  • The MSP targets approximately 50% of annual breast cancer cases in Germany.
  • Ten years post-implementation, the MSP led to a quarter reduction in advanced breast cancer stages and mortality within the screened group.
  • No significant trends in mortality were observed in non-screened neighboring age groups.

Conclusions:

  • The MSP has demonstrably reduced breast cancer mortality.
  • Expanding the MSP to ages 45-75 years enhances access to structured, quality-assured screening.
  • Future optimization of the MSP may involve advanced diagnostics, stratification, and artificial intelligence.